Related Experiment Video
Updated: Nov 17, 2025
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
Published on: October 26, 2017
miRNAs and Biomarkers in Testicular Germ Cell Tumors: An Update
Marco De Martino1,2, Paolo Chieffi3, Francesco Esposito1
1Istituto di Endocrinologia ed Oncologia Sperimentale-CNR c/o Dipartimento di Medicina Molecolare e Biotecnologie Mediche, Università degli Studi di Napoli "Federico II", Napoli 80131, Italy.
Abstract:
Testicular germ cell tumors (TGCTs) are the leading form of solid cancer and death affecting males between the ages of 20 and 40. Today, their surgical resection and chemotherapy are the treatments of first choice, even if sometimes this is not enough to save the lives of patients with TGCT. As seen for several tumors, the deregulation of microRNAs (miRNAs) is also a key feature in TGCTs. miRNAs are small molecules of RNA with biological activity that are released into biological fluids by testicular cancer cells. Their presence, therefore, can be detected and monitored by considering miRNAs as diagnostic and prognostic markers for TGCTs. The purpose of this review is to collect all the studies executed on miRNAs that have a potential role as biomarkers for testicular tumors.
Insights
MicroRNAs (miRNAs) show potential as diagnostic and prognostic biomarkers for testicular germ cell tumors (TGCTs). This review collects studies on miRNAs, offering hope for improved TGCT detection and monitoring.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Testicular germ cell tumors (TGCTs) are the primary solid cancer in males aged 20-40.
- Current treatments like surgery and chemotherapy are not always sufficient for TGCT patients.
- MicroRNA (miRNA) deregulation is a significant characteristic observed in various cancers, including TGCTs.
Purpose of the Study:
- To compile and review existing research on microRNAs (miRNAs) as potential biomarkers for testicular tumors.
- To highlight the diagnostic and prognostic value of miRNAs in the context of TGCTs.
Main Methods:
- Systematic literature search for studies investigating miRNAs in testicular cancer.
- Analysis of identified studies focusing on miRNA detection and their correlation with TGCT diagnosis and prognosis.
Main Results:
- MicroRNAs (miRNAs) are released by testicular cancer cells into biological fluids.
- These miRNAs can be detected and monitored, indicating their potential as biomarkers.
- Deregulation of specific miRNAs is a key feature in TGCT development and progression.
Conclusions:
- MicroRNAs (miRNAs) represent promising diagnostic and prognostic markers for testicular germ cell tumors (TGCTs).
- Further research into miRNAs could lead to improved methods for TGCT detection, monitoring, and potentially, treatment strategies.
